Dr. Karen Pierce used Patient Services when her mother and husband were diagnosed with pancreatic cancer – then she used it ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...
Sue Popik, a pancreatic cancer survivor and member of PanCAN’s Volunteer Advisory Council (VAC), shares her thanks for PanCAN ...
With federal research budgets facing growing uncertainty, PanCAN remains committed to building a research ecosystem to ...
Pancreatic cancer survivor and PanCAN volunteer Tolair Jones shares her journey with three types of cancer and what motivated her to get involved with PanCAN.
This Pancreatic Cancer Awareness Month, PanCAN is inviting you to shine a light on pancreatic cancer. Let’s uplift survivors and those living with the disease, honor the lives we’ve lost and help ...
LOS ANGELES, CALIF. – (July 2, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, today announced a new data partnership ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...
The U.S. Food & Drug Administration has granted approval for a new drug to treat pancreatic neuroendocrine tumors, also called PNET or PanNET. “I am delighted that patients with pancreatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback